|
|
|
|
| LEADER |
01279nam a2200265 a 4500 |
| 001 |
000000035028 |
| 003 |
OSt |
| 005 |
20160424091634.0 |
| 008 |
160424b us ||||| |||| 00| 0 eng d |
| 040 |
|
|
|a Sistema de Bibliotecas UNAH
|
| 082 |
0 |
|
|a 658.8096151-S65
|
| 100 |
0 |
|
|a Smith, Mickey C
|
| 245 |
0 |
3 |
|a Principles of pharmaceutical marketing
|c Mickey C. Smith
|
| 260 |
|
|
|c 1975
|a Philadelphia, United States
|b Lea and Febiger
|
| 300 |
|
|
|a 440p.
|b il. , diagrs. tablas
|
| 504 |
|
|
|a Bibliografia: fin de cap.
|
| 650 |
|
4 |
|a IINDUSTRIA FARMACEUTICA-ESTADOS UNIDOS
|
| 942 |
|
|
|2 ddc
|c LB
|
| 999 |
|
|
|c 35028
|d 35028
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113154
|a CG
|b BC
|l 0
|o 658.8096151-S65
|p 407914
|y LB
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113155
|a CG
|b BC
|l 0
|o 658.8096151-S65
|p 407915
|y LB
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113156
|a CG
|b BC
|l 0
|o 658.8096151-S65
|p 407916
|y LB
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113157
|a CG
|b BM
|l 0
|o 658.8096151-S65
|p 415008
|y LB
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113158
|a BLA
|b BLA
|l 0
|o 658.8096151-S65
|p BLA130792210
|y LB
|
| 952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 658_000000000000000_8096151S65
|7 0
|9 113159
|a BVS
|b BVS
|l 0
|o 658.8096151-S65
|p BVS130792211
|y LB
|